Ever Source Wealth Advisors, LLC Maxcyte, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 114 shares of MXCT stock, worth $500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114Holding current value
$500% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding MXCT
# of Institutions
125Shares Held
67.4MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$35.9 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$35.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$25.4 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$22.1 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$21.1 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $447M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...